
CVS Health rose 10.1% from $77.94 to $85.81, behind the S&P 500's +11.0%. Its worst day was Jan 27 (−14.2%), and its low came Mar 27 at $70.08.
Nov 18, 2025 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
CVS Health shares fell 6.7%, while the S&P 500 rose 0.1%.
−6.7% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Health insurer stocks are tumbling after the market close on Monday following a report indicating the Trump administration will propose essentially unchanged rates for Medicare insurers next year.
−14.2%, the year's worst day, on 44M shares, the year's heaviest volume · S&P 500 +0.4%
EPS of $1.09 beat the $0.99 estimate on $105.7B revenue (est. $103.5B); FY revenue guidance of $400.0B against the $408.4B consensus.
−0.1% · S&P 500 −0.3%
CVS Health closed at its lowest level of the year, 10.1% below where the year started.
−1.5% · S&P 500 −1.7%
CVS Health Corp (NYSE: CVS) shares are trading higher Tuesday after the CMS finalized 2027 Medicare Advantage and Part D payment policies.
+6.7% · S&P 500 0.0%
EPS of $2.57 beat the $2.21 estimate on $100.4B revenue (est. $94.9B); FY revenue guidance of $405.0B against the $405.4B consensus.
+7.6%, the year's best day · S&P 500 +1.4%
CVS Health closed at its highest level of the year, 41.9% above where the year started.
+2.8% · S&P 500 +0.8%
EPS of $2.58 beat the $1.84 estimate on $106.1B revenue (est. $100.1B); FY revenue guidance of $414.0B against the $409.2B consensus.
−5.1% · S&P 500 −0.2%
EPS of $2.09 beat the $1.64 estimate on $108.4B revenue (est. $104.8B); FY revenue guidance of $420.0B against the $417.9B consensus.
−12.5% · S&P 500 +1.7%
Where it ended: a close of $85.81 on Nov 17, 2026. Up next: Q4 2026 earnings on Feb 9, 2027 (EPS est. $1.06, revenue est. $107.6B).
As of the Nov 17, 2026 close
Replay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CVS and SPY from Benzinga historical bars. Not investment advice.